Challenges of Delivering Diabetes Care During the Covid 19 Pandemic

Susan E Jones

doi:10.70302/jpsim.v2i3.2143

Editorial

Challenges of Delivering Diabetes Care During the Covid 19 Pandemic

Susan E Jones

North Tees University Hospital, Stockton on Tees, UK. Newcastle University Medical School

✉ Correspondence: Susan E Jones Email: sue.jones20@nhs.net

DOI https://doi.org/10.70302/jpsim.v2i3.2143

Volume: 2, Issue 3 Pages: 186–187 Published: 20 Sep 2021

Received: 26 May 2021 Accepted: 13 Aug 2021 Published Online: 20 Sep 2021

Abstract

How to Cite This Article

Jones SE. Challenges of Delivering Diabetes Care During the Covid 19 Pandemic. J Pak Soc Intern Med. 2021;2(3):186–187. doi:10.70302/jpsim.v2i3.2143

⭳ Download PDF

Download Citation: ⭳ RIS (Endnote / Zotero / Mendeley) ⭳ BibTeX (.bib)

Conflict of Interest

All authors declare no competing interests.

Disclosed in accordance with ICMJE and COPE guidelines.

Funding

No specific funding was received for this research.

Funder information follows the Crossref Funder Registry standard.

References

NHS Attend Anywhere. [ Cited July 2021] Available from: [https://england.nhs.attendanywhere.com/resourcecentre/Content/Home.htm]
Iyengar K, Jain VK, Vaishya R. Pitfalls in telemedicine consultations in the era of COVID 19 and how to avoid them. Diabetes & Metabolic Syndrome: Clin Res Rev. 2020 ;14(5):797-9.
Marsalek K, Pevtrignet S. Understanding the needs of the most clinically vulnerable to COVID-19. Unanswered questions about the shielded population. The Health Foundation. [Updated 2020, cited 2021] Available from: [https://www.health.org.uk/news-and-comment/charts-and-infographics/understanding-the-needs-and-experiences-of-those-most-clinic]
Rayman G, Lumb A, Kennon B, Cottrell C, Nagi D, Page E, et al. New Guidance on Managing Inpatient Hyperglycaemia during the COVID-19 Pandemic. Diabetic Medicine, 2020;37(7): 1210-13.
The RECOVERY Trial Group. [Udated 2020, cited 2021] Available from: [https://www.recoverytrial.net/]
The RECOVERY Collaborative Group. Dexamethasone in Hospitalized Patients with COVID-19 – Preliminary Report. NEJM 2020;doi.10.1056/NEJMoa2021436 doi:10.1056/NEJMoa2021436
Rubino F, Amiel S, Zimmet P, Alberti G, Bornstein S, Eckel R et,al. New Onset Diabetes in COVID-19. NEJM 2020;383(8):789 -90
Taylor S, Blau J, Rother K. SGLT2 Inhibitors May Predispose to Ketoacidosis. J Clin Endo Metab. 2015; 100 (8):2849-52
Kosiborod M, Esterline R, Futado R, Ocarsson J, Gasparyan S, Koch G et al. Dapagliflozin in patients with cardiometabolic risk factors hospitalised with COVID-19 (DARE-19): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Diab Endocrinol. 2021;9(9):586 -94.

Reference list indexed for Google Scholar and ResearchGate. DOI links resolve via doi.org.

CC BY 4.0 This article is published under the Creative Commons Attribution 4.0 International License. May be shared and adapted with attribution. © 2021 Journal of Pakistan Society of Internal Medicine.

📃 In This Issue View All

Review Article Thyroid Disorders in Pregnancy: Clinical Implications and Management Strategies Baig BI, Usman A Review Article Antibiotic Resistance Patterns in Community-Acquired Pneumonia: Emerging Trends Hussain I, Farooq Z Review Article Statin Therapy in Non-Alcoholic Fatty Liver Disease: A Systematic Review Nawaz F, Cheema HA, Mehmood Y Original Article Neonatal Sepsis: Bacteriological Profile and Antibiogram in a Tertiary Care Hospital Iqbal M, Rashid T Original Article Comparison of Ultrasound-Guided versus Landmark-Based Central Venous Catheter Insertion Zafar S, Gillani SA

👥 More by These Authors

Original Article Prevalence of Hypertension Among Urban Adults in Pakistan: A Cross-Sectional Study Khan TM, Ahmed S, Malik RA Original Article Outcomes of Laparoscopic Cholecystectomy in Acute Cholecystitis: A Retrospective Analysis Raza SH, Butt N, Qureshi AM Original Article Serum Ferritin as a Prognostic Marker in COVID-19 Severity: A Hospital-Based Study Rehman N, Sheikh I, Javed K Original Article Cervical Cancer Screening Awareness Among Rural Women in Punjab Bibi S, Anjum R, Hassan F

🔗 Related Articles By Keywords

Review Article Statin Therapy in Non-Alcoholic Fatty Liver Disease: A Systematic Review Nawaz F, Cheema HA, Mehmood Y Original Article Neonatal Sepsis: Bacteriological Profile and Antibiogram in a Tertiary Care Hospital Iqbal M, Rashid T Original Article Comparison of Ultrasound-Guided versus Landmark-Based Central Venous Catheter Insertion Zafar S, Gillani SA Original Article Impact of Diabetes Mellitus on Post-Operative Wound Healing in General Surgery Siddiqui FA, Noor M, Akhtar W

[1] NHS Attend Anywhere. [ Cited July 2021] Available from: [https://england.nhs.attendanywhere.com/resourcecentre/Content/Home.htm]

[2] Iyengar K, Jain VK, Vaishya R. Pitfalls in telemedicine consultations in the era of COVID 19 and how to avoid them. Diabetes & Metabolic Syndrome: Clin Res Rev. 2020 ;14(5):797-9.

[3] Marsalek K, Pevtrignet S. Understanding the needs of the most clinically vulnerable to COVID-19. Unanswered questions about the shielded population. The Health Foundation. [Updated 2020, cited 2021] Available from: [https://www.health.org.uk/news-and-comment/charts-and-infographics/understanding-the-needs-and-experiences-of-those-most-clinic]

[4] Rayman G, Lumb A, Kennon B, Cottrell C, Nagi D, Page E, et al. New Guidance on Managing Inpatient Hyperglycaemia during the COVID-19 Pandemic. Diabetic Medicine, 2020;37(7): 1210-13.

[5] The RECOVERY Trial Group. [Udated 2020, cited 2021] Available from: [https://www.recoverytrial.net/]

[6] The RECOVERY Collaborative Group. Dexamethasone in Hospitalized Patients with COVID-19 – Preliminary Report. NEJM 2020;doi.10.1056/NEJMoa2021436 doi:10.1056/NEJMoa2021436

[7] Rubino F, Amiel S, Zimmet P, Alberti G, Bornstein S, Eckel R et,al. New Onset Diabetes in COVID-19. NEJM 2020;383(8):789 -90

[8] Taylor S, Blau J, Rother K. SGLT2 Inhibitors May Predispose to Ketoacidosis. J Clin Endo Metab. 2015; 100 (8):2849-52

[9] Kosiborod M, Esterline R, Futado R, Ocarsson J, Gasparyan S, Koch G et al. Dapagliflozin in patients with cardiometabolic risk factors hospitalised with COVID-19 (DARE-19): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Diab Endocrinol. 2021;9(9):586 -94.